Models of Madness: Psychological, Social and Biological Approaches to Psychosis. London: Routledge, 2013-07-17. ISBN 9780415579537. Teoksen verkkoversio (viitattu 23.12.2017). English
Thomas Szasz: Schizophrenia: The Sacred Symbol of Psychiatry. Syracuse, NY: Syracuse University Publications in Continuing Education, 2004-01-01. ISBN 9780815602248. Teoksen verkkoversio (viitattu 21.12.2017). English
Jay Joseph: The Gene Illusion - Genetic Research in Psychiatry and Psychology Under the Microscope. New York: Algora Publishing, 2004-02-02. ISBN 9780875863436. Teoksen verkkoversio (viitattu 23.12.2017). English
Royal College of Psychiatrists and British Psychological Society BMJ Publishing Group Ltd: Review: at least one third of people report persistent memory loss after electroconvulsive therapy. Evidence-Based Mental Health, 1.2.2004, 7. vsk, nro 1, s. 27–27. PubMed:14769671. doi:10.1136/ebmh.7.1.27. ISSN 1362-0347. Artikkelin verkkoversio. en
M. Koskenvuo, H. Langinvainio, J. Kaprio, J. Lönnqvist, P. Tienari: Psychiatric Hospitalization in Twins. Acta geneticae medicae et gemellologiae: twin research, 1984/04, nro 2, s. 321–332. doi:10.1017/S0001566000007364. ISSN 0001-5660. Artikkelin verkkoversio.
Kelly, Ciara & McCreadie, Robin: Cigarette smoking and schizophreniaAdvances in Psychiatric Treatment. 2000. The Royal College of Psychiatrists. Viitattu 17.5.2021.
Saha, S., Chant, D., McGrath, J.: A systematic review of mortality in schizophrenia - Is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 64(10) pp. 1123–1131, 2007. Artikkelin verkkoversio.
doi.org
dx.doi.org
J. Karagianis, D. Novick, J. Pecenak, J. M. Haro, M. Dossenbach, T. Treuer: Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*. International Journal of Clinical Practice, 1.11.2009, nro 11, s. 1578–1588. doi:10.1111/j.1742-1241.2009.02191.x. ISSN 1742-1241. Artikkelin verkkoversio. en
Jukka Aaltonen, Jaakko Seikkula, Klaus Lehtinen: The Comprehensive Open-Dialogue Approach in Western Lapland: I. The incidence of non-affective psychosis and prodromal states. Psychosis, 1.10.2011, nro 3, s. 179–191. doi:10.1080/17522439.2011.601750. ISSN 1752-2439. Artikkelin verkkoversio.
Silvia Sorce, Stefania Schiavone, Paolo Tucci, Marilena Colaianna, Vincent Jaquet, Vincenzo Cuomo: The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25.8.2010, nro 34, s. 11317–11325. PubMed:20739552. doi:10.1523/JNEUROSCI.1491-10.2010. ISSN 1529-2401. Artikkelin verkkoversio.
Marie-Caroline Cotel & Ewelina M. Lenartowicz & Sridhar Natesan & Michel M. Modo & Jonathan D. Cooper & Steven C. R. Williams: Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. European Neuropsychopharmacology, 1.11.2015, nro 11, s. 2098–2107. doi:10.1016/j.euroneuro.2015.08.004. ISSN 0924-977X. Artikkelin verkkoversio. English
Louise Arseneault, Mary Cannon, Helen L. Fisher, Guilherme Polanczyk, Terrie E. Moffitt, Avshalom Caspi: Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. The American Journal of Psychiatry, January 2011, nro 1, s. 65–72. PubMed:20952460. doi:10.1176/appi.ajp.2010.10040567. ISSN 1535-7228. Artikkelin verkkoversio.
Anne Marsman, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak: Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?. Schizophrenia Bulletin, 1.12.2020, nro 6, s. 1353–1362. doi:10.1093/schbul/sbaa086. ISSN 0586-7614. Artikkelin verkkoversio. en
Alexandros Rammos, Lara A. Neira Gonzalez, Daniel R. Weinberger, Kevin J. Mitchell, Kristin K. Nicodemus: The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia. Neuropsychopharmacology, 2019-08, nro 9, s. 1562–1569. doi:10.1038/s41386-019-0410-z. ISSN 1740-634X. Artikkelin verkkoversio. en
M. Koskenvuo, H. Langinvainio, J. Kaprio, J. Lönnqvist, P. Tienari: Psychiatric Hospitalization in Twins. Acta geneticae medicae et gemellologiae: twin research, 1984/04, nro 2, s. 321–332. doi:10.1017/S0001566000007364. ISSN 0001-5660. Artikkelin verkkoversio.
William Pollin, Martin G. Allen, Axel Hoffer, James R. Stabenau, Zdenek Hrubec: Psychopathology in 15,909 Pairs of Veteran Twins: Evidence for a Genetic Factor in the Pathogenesis of Schizophrenia and Its Relative Absence in Psychoneurosis. American Journal of Psychiatry, 1.11.1969, nro 5, s. 597–610. doi:10.1176/ajp.126.5.597. ISSN 0002-953X. Artikkelin verkkoversio.
Carol A. Prescott, Jonathan W. Kuhn, Nancy L. Pedersen: Twin Pair Resemblance for Psychiatric Hospitalization in the Swedish Twin Registry: A 32-year Follow-up Study of 29,602 Twin Pairs. Behavior Genetics, 1.7.2007, nro 4, s. 547–558. doi:10.1007/s10519-007-9143-6. ISSN 0001-8244. Artikkelin verkkoversio. en
Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741. doi:10.1176/appi.ajp.2011.10081224. ISSN 1535-7228. Artikkelin verkkoversio.
Peter Lepping, Rajvinder Singh Sambhi, Richard Whittington, Steven Lane, Rob Poole: Clinical relevance of findings in trials of antipsychotics: systematic review. The British Journal of Psychiatry: The Journal of Mental Science, 2011-05, nro 5, s. 341–345. PubMed:21525517. doi:10.1192/bjp.bp.109.075366. ISSN 1472-1465. Artikkelin verkkoversio.
Stefan Leucht, Claudia Leucht, Maximilian Huhn, Anna Chaimani, Dimitris Mavridis, Bartosz Helfer: Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry, 25.5.2017, nro 10, s. 927–942. doi:10.1176/appi.ajp.2017.16121358. ISSN 0002-953X. Artikkelin verkkoversio.
Ni A. Khin, Yeh-Fong Chen, Yang Yang, Peiling Yang, Thomas P. Laughren: Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. The Journal of Clinical Psychiatry, 2012-06, nro 6, s. 856–864. PubMed:22687813. doi:10.4088/JCP.11r07539. ISSN 1555-2101. Artikkelin verkkoversio.
Alexander M. Récalt, David Cohen: Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017. Psychotherapy and Psychosomatics, 2019, nro 2, s. 105–113. PubMed:30893683. doi:10.1159/000496734. ISSN 1423-0348. Artikkelin verkkoversio.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607. doi:10.1016/S0140-6736(12)60239-6. ISSN 0140-6736. Artikkelin verkkoversio. English
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, {{{Vuosi}}}, nro 4, s. 193–201. PubMed:31561392. doi:10.3233/JRS-195063. ISSN 0924-6479. Artikkelin verkkoversio.
Tomi Bergström, Jyri J. Taskila, Birgitta Alakare, Päivi Köngäs-Saviaro, Jouko Miettunen, Jaakko Seikkula: Five-Year Cumulative Exposure to Antipsychotic Medication After First-Episode Psychosis and its Association With 19-Year Outcomes. Schizophrenia Bulletin Open, 1.1.2020, nro 1. doi:10.1093/schizbullopen/sgaa050. Artikkelin verkkoversio. en
J. Moilanen, M. Haapea, J. Miettunen, E. Jääskeläinen, J. Veijola, M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, 2013-01, nro 1, s. 53–58. PubMed:21920710. doi:10.1016/j.eurpsy.2011.06.009. ISSN 1778-3585. Artikkelin verkkoversio.
Roman Kotov, Laura Fochtmann, Kaiqiao Li, Marsha Tanenberg-Karant, Eduardo A. Constantino, Joan Rubinstein: Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. The American Journal of Psychiatry, 11 01, 2017, nro 11, s. 1064–1074. PubMed:28774193. doi:10.1176/appi.ajp.2017.16101191. ISSN 1535-7228. Artikkelin verkkoversio.
Royal College of Psychiatrists and British Psychological Society BMJ Publishing Group Ltd: Review: at least one third of people report persistent memory loss after electroconvulsive therapy. Evidence-Based Mental Health, 1.2.2004, 7. vsk, nro 1, s. 27–27. PubMed:14769671. doi:10.1136/ebmh.7.1.27. ISSN 1362-0347. Artikkelin verkkoversio. en
Jari Tiihonen, Jouko Lönnqvist, Kristian Wahlbeck, Timo Klaukka, Leo Niskanen, Antti Tanskanen: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (London, England), 22.8.2009, nro 9690, s. 620–627. PubMed:19595447. doi:10.1016/S0140-6736(09)60742-X. ISSN 1474-547X. Artikkelin verkkoversio.
Marc De Hert, Christoph U. Correll, Dan Cohen: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, March 2010, nro 1, s. 68–74. PubMed:20060684. doi:10.1016/j.schres.2009.12.029. ISSN 1573-2509. Artikkelin verkkoversio.
Marc De Hert, Christoph U. Correll, Dan Cohen: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, 1.3.2010, nro 1, s. 68–74. doi:10.1016/j.schres.2009.12.029. ISSN 0920-9964. Artikkelin verkkoversio. en
Steven Marwaha, Sonia Johnson, Paul Bebbington, Mai Stafford, Matthias C. Angermeyer, Traolach Brugha: Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. The British Journal of Psychiatry, 2007-07-01 (kohorttitutkimus julkaistu v. 2005), nro 1, s. 30–37. The Royal College of Psychiatrists. PubMed:17602122. doi:10.1192/bjp.bp.105.020982. ISSN 0007-1250. Artikkelin verkkoversio. en
Natasha A. Schvey, Rebecca M. Puhl, Kelly D. Brownell: The Stress of Stigma: Exploring the Effect of Weight Stigma on Cortisol Reactivity. Psychosomatic Medicine, February/March 2014, nro 2, s. 156. doi:10.1097/PSY.0000000000000031. ISSN 0033-3174. Artikkelin verkkoversio.
doi.org
Jukka Aaltonen, Jaakko Seikkula, Klaus Lehtinen: The Comprehensive Open-Dialogue Approach in Western Lapland: I. The incidence of non-affective psychosis and prodromal states. Psychosis, 1.10.2011, nro 3, s. 179–191. doi:10.1080/17522439.2011.601750. ISSN 1752-2439. Artikkelin verkkoversio.
duodecimlehti.fi
Räsänen, Sami ym.: Missä iässä skitsofrenia alkaa?. Lääketieteellinen Aikakauskirja Duodecim, 1997, nro 24, s. 2595–2597. Suomalainen Lääkäriseura Duodecim. Artikkelin verkkoversio. Viitattu 11.10.2016.
Kaprio, Jaakko & Lönnqvist, Jouko: Onko skitsofrenia perinnöllinen sairaus?. Lääketieteellinen Aikakauskirja Duodecim, 1997, nro 24, s. 2589. Artikkelin verkkoversio. Viitattu 11.10.2016.
Suvisaari, Jaana ym.: Psykoosien esiintyvyys ja alueellinen vaihtelu Suomessa. Lääkärilehti, 2.3.2012, 67. vsk, nro 9, s. 677–683. Suomen Lääkäriliitto. Artikkelin verkkoversio. Viitattu 11.10.2016.
Jaakko Seikkula, Birgitta Alakare, Jukka Aaltonen, Juha Holma, Anu Rasinkangas, Ville Lehtinen: Open Dialogue Approach: Treatment Principles and Preliminary Results of a Two-Year Follow-Up on First Episode Schizophrenia. Ethical Human Sciences and Services, 1.1.2003, nro 3, s. 163–182. Artikkelin verkkoversio.
Natasha A. Schvey, Rebecca M. Puhl, Kelly D. Brownell: The Stress of Stigma: Exploring the Effect of Weight Stigma on Cortisol Reactivity. Psychosomatic Medicine, February/March 2014, nro 2, s. 156. doi:10.1097/PSY.0000000000000031. ISSN 0033-3174. Artikkelin verkkoversio.
madinfinland.org
Keitä olemme?Mad In Finland - Hulluna Suomessa. Viitattu 24.4.2022.
Alexandros Rammos, Lara A. Neira Gonzalez, Daniel R. Weinberger, Kevin J. Mitchell, Kristin K. Nicodemus: The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia. Neuropsychopharmacology, 2019-08, nro 9, s. 1562–1569. doi:10.1038/s41386-019-0410-z. ISSN 1740-634X. Artikkelin verkkoversio. en
K. Hopper, J. Wanderling: Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophrenia Bulletin, 2000, nro 4, s. 835–846. PubMed:11087016. ISSN 0586-7614. Artikkelin verkkoversio.
Silvia Sorce, Stefania Schiavone, Paolo Tucci, Marilena Colaianna, Vincent Jaquet, Vincenzo Cuomo: The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25.8.2010, nro 34, s. 11317–11325. PubMed:20739552. doi:10.1523/JNEUROSCI.1491-10.2010. ISSN 1529-2401. Artikkelin verkkoversio.
M. Boyle: Is schizophrenia what it was? A re-analysis of Kraepelin's and Bleuler's population. Journal of the History of the Behavioral Sciences, October 1990, nro 4, s. 323–333. PubMed:2254639. ISSN 0022-5061. Artikkelin verkkoversio.
Louise Arseneault, Mary Cannon, Helen L. Fisher, Guilherme Polanczyk, Terrie E. Moffitt, Avshalom Caspi: Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. The American Journal of Psychiatry, January 2011, nro 1, s. 65–72. PubMed:20952460. doi:10.1176/appi.ajp.2010.10040567. ISSN 1535-7228. Artikkelin verkkoversio.
P. McGuffin, A. E. Farmer, I. I. Gottesman, R. M. Murray, A. M. Reveley: Twin concordance for operationally defined schizophrenia. Confirmation of familiality and heritability. Archives of General Psychiatry, June 1984, nro 6, s. 541–545. PubMed:6539584. ISSN 0003-990X. Artikkelin verkkoversio.
Svenn Torgersen: [Genetics and somatoform disorders]. Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, Ny Raekke, 30.5.2002, nro 14, s. 1385–1388. PubMed:12098908. ISSN 0029-2001. Artikkelin verkkoversio.
J. C. Loehlin: Identical twins reared apart and other routes to the same destination. Progress in Clinical and Biological Research, 1978, nro 24A, s. 69–77. PubMed:568284. ISSN 0361-7742. Artikkelin verkkoversio.
Norbert Müller, Markus J. Schwarz: Immune System and Schizophrenia. Current immunology reviews, 2010-8, nro 3, s. 213–220. PubMed:21057585. ISSN 1573-3955. Artikkelin verkkoversio.
Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741. doi:10.1176/appi.ajp.2011.10081224. ISSN 1535-7228. Artikkelin verkkoversio.
Peter Lepping, Rajvinder Singh Sambhi, Richard Whittington, Steven Lane, Rob Poole: Clinical relevance of findings in trials of antipsychotics: systematic review. The British Journal of Psychiatry: The Journal of Mental Science, 2011-05, nro 5, s. 341–345. PubMed:21525517. doi:10.1192/bjp.bp.109.075366. ISSN 1472-1465. Artikkelin verkkoversio.
Ni A. Khin, Yeh-Fong Chen, Yang Yang, Peiling Yang, Thomas P. Laughren: Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. The Journal of Clinical Psychiatry, 2012-06, nro 6, s. 856–864. PubMed:22687813. doi:10.4088/JCP.11r07539. ISSN 1555-2101. Artikkelin verkkoversio.
Alexander M. Récalt, David Cohen: Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017. Psychotherapy and Psychosomatics, 2019, nro 2, s. 105–113. PubMed:30893683. doi:10.1159/000496734. ISSN 1423-0348. Artikkelin verkkoversio.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607. doi:10.1016/S0140-6736(12)60239-6. ISSN 0140-6736. Artikkelin verkkoversio. English
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, {{{Vuosi}}}, nro 4, s. 193–201. PubMed:31561392. doi:10.3233/JRS-195063. ISSN 0924-6479. Artikkelin verkkoversio.
J. Moilanen, M. Haapea, J. Miettunen, E. Jääskeläinen, J. Veijola, M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, 2013-01, nro 1, s. 53–58. PubMed:21920710. doi:10.1016/j.eurpsy.2011.06.009. ISSN 1778-3585. Artikkelin verkkoversio.
Roman Kotov, Laura Fochtmann, Kaiqiao Li, Marsha Tanenberg-Karant, Eduardo A. Constantino, Joan Rubinstein: Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. The American Journal of Psychiatry, 11 01, 2017, nro 11, s. 1064–1074. PubMed:28774193. doi:10.1176/appi.ajp.2017.16101191. ISSN 1535-7228. Artikkelin verkkoversio.
Royal College of Psychiatrists and British Psychological Society BMJ Publishing Group Ltd: Review: at least one third of people report persistent memory loss after electroconvulsive therapy. Evidence-Based Mental Health, 1.2.2004, 7. vsk, nro 1, s. 27–27. PubMed:14769671. doi:10.1136/ebmh.7.1.27. ISSN 1362-0347. Artikkelin verkkoversio. en
A. Jablensky, N. Sartorius, G. Ernberg, M. Anker, A. Korten, J. E. Cooper: Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine. Monograph Supplement, 1992, nro 20, s. 1–97. PubMed:1565705. ISSN 0264-1801. Artikkelin verkkoversio.
Jari Tiihonen, Jouko Lönnqvist, Kristian Wahlbeck, Timo Klaukka, Leo Niskanen, Antti Tanskanen: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (London, England), 22.8.2009, nro 9690, s. 620–627. PubMed:19595447. doi:10.1016/S0140-6736(09)60742-X. ISSN 1474-547X. Artikkelin verkkoversio.
Marc De Hert, Christoph U. Correll, Dan Cohen: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, March 2010, nro 1, s. 68–74. PubMed:20060684. doi:10.1016/j.schres.2009.12.029. ISSN 1573-2509. Artikkelin verkkoversio.
Steven Marwaha, Sonia Johnson, Paul Bebbington, Mai Stafford, Matthias C. Angermeyer, Traolach Brugha: Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. The British Journal of Psychiatry, 2007-07-01 (kohorttitutkimus julkaistu v. 2005), nro 1, s. 30–37. The Royal College of Psychiatrists. PubMed:17602122. doi:10.1192/bjp.bp.105.020982. ISSN 0007-1250. Artikkelin verkkoversio. en
ncbi.nlm.nih.gov
K. Hopper, J. Wanderling: Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophrenia Bulletin, 2000, nro 4, s. 835–846. PubMed:11087016. ISSN 0586-7614. Artikkelin verkkoversio.
Silvia Sorce, Stefania Schiavone, Paolo Tucci, Marilena Colaianna, Vincent Jaquet, Vincenzo Cuomo: The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25.8.2010, nro 34, s. 11317–11325. PubMed:20739552. doi:10.1523/JNEUROSCI.1491-10.2010. ISSN 1529-2401. Artikkelin verkkoversio.
Ahbishekh Hulegar Ashok, John Baugh, and Vikram K. Yeragani: Paul Eugen Bleuler and the origin of the term schizophrenia (SCHIZOPRENIEGRUPPE). Indian Journal of Psychiatry. 2012 Jan-Mar; 54(1): 95–96. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339235/
M. Boyle: Is schizophrenia what it was? A re-analysis of Kraepelin's and Bleuler's population. Journal of the History of the Behavioral Sciences, October 1990, nro 4, s. 323–333. PubMed:2254639. ISSN 0022-5061. Artikkelin verkkoversio.
Louise Arseneault, Mary Cannon, Helen L. Fisher, Guilherme Polanczyk, Terrie E. Moffitt, Avshalom Caspi: Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. The American Journal of Psychiatry, January 2011, nro 1, s. 65–72. PubMed:20952460. doi:10.1176/appi.ajp.2010.10040567. ISSN 1535-7228. Artikkelin verkkoversio.
P. McGuffin, A. E. Farmer, I. I. Gottesman, R. M. Murray, A. M. Reveley: Twin concordance for operationally defined schizophrenia. Confirmation of familiality and heritability. Archives of General Psychiatry, June 1984, nro 6, s. 541–545. PubMed:6539584. ISSN 0003-990X. Artikkelin verkkoversio.
Svenn Torgersen: [Genetics and somatoform disorders]. Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, Ny Raekke, 30.5.2002, nro 14, s. 1385–1388. PubMed:12098908. ISSN 0029-2001. Artikkelin verkkoversio.
J. C. Loehlin: Identical twins reared apart and other routes to the same destination. Progress in Clinical and Biological Research, 1978, nro 24A, s. 69–77. PubMed:568284. ISSN 0361-7742. Artikkelin verkkoversio.
Norbert Müller, Markus J. Schwarz: Immune System and Schizophrenia. Current immunology reviews, 2010-8, nro 3, s. 213–220. PubMed:21057585. ISSN 1573-3955. Artikkelin verkkoversio.
^ Shibayama M (2011). "Differential diagnosis between dissociative disorders and schizophrenia". Seishin shinkeigaku zasshi=Psychiatria et neurologia Japonica 113 (9): 906–911. PMID 22117396.
Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741. doi:10.1176/appi.ajp.2011.10081224. ISSN 1535-7228. Artikkelin verkkoversio.
National Center for Biotechnology Information, U. S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 Usa: VALIDITY OF PSYCHIATRIC SYMPTOM SCALES AND CLINICAL IMPLICATIONS. Canadian Agency for Drugs and Technologies in Health, 2011/12. Teoksen verkkoversio (viitattu 6.3.2021). en
National Center for Biotechnology Information, U. S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 Usa: VALIDITY OF PSYCHIATRIC SYMPTOM SCALES AND CLINICAL IMPLICATIONS. Canadian Agency for Drugs and Technologies in Health, 2011/12. Teoksen verkkoversio (viitattu 7.3.2021). en
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, {{{Vuosi}}}, nro 4, s. 193–201. PubMed:31561392. doi:10.3233/JRS-195063. ISSN 0924-6479. Artikkelin verkkoversio.
A. Jablensky, N. Sartorius, G. Ernberg, M. Anker, A. Korten, J. E. Cooper: Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine. Monograph Supplement, 1992, nro 20, s. 1–97. PubMed:1565705. ISSN 0264-1801. Artikkelin verkkoversio.
Jari Tiihonen, Jouko Lönnqvist, Kristian Wahlbeck, Timo Klaukka, Leo Niskanen, Antti Tanskanen: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (London, England), 22.8.2009, nro 9690, s. 620–627. PubMed:19595447. doi:10.1016/S0140-6736(09)60742-X. ISSN 1474-547X. Artikkelin verkkoversio.
Marc De Hert, Christoph U. Correll, Dan Cohen: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, March 2010, nro 1, s. 68–74. PubMed:20060684. doi:10.1016/j.schres.2009.12.029. ISSN 1573-2509. Artikkelin verkkoversio.
Anne Marsman, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak: Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?. Schizophrenia Bulletin, 1.12.2020, nro 6, s. 1353–1362. doi:10.1093/schbul/sbaa086. ISSN 0586-7614. Artikkelin verkkoversio. en
Tomi Bergström, Jyri J. Taskila, Birgitta Alakare, Päivi Köngäs-Saviaro, Jouko Miettunen, Jaakko Seikkula: Five-Year Cumulative Exposure to Antipsychotic Medication After First-Episode Psychosis and its Association With 19-Year Outcomes. Schizophrenia Bulletin Open, 1.1.2020, nro 1. doi:10.1093/schizbullopen/sgaa050. Artikkelin verkkoversio. en
William Pollin, Martin G. Allen, Axel Hoffer, James R. Stabenau, Zdenek Hrubec: Psychopathology in 15,909 Pairs of Veteran Twins: Evidence for a Genetic Factor in the Pathogenesis of Schizophrenia and Its Relative Absence in Psychoneurosis. American Journal of Psychiatry, 1.11.1969, nro 5, s. 597–610. doi:10.1176/ajp.126.5.597. ISSN 0002-953X. Artikkelin verkkoversio.
Stefan Leucht, Claudia Leucht, Maximilian Huhn, Anna Chaimani, Dimitris Mavridis, Bartosz Helfer: Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry, 25.5.2017, nro 10, s. 927–942. doi:10.1176/appi.ajp.2017.16121358. ISSN 0002-953X. Artikkelin verkkoversio.
Steven Marwaha, Sonia Johnson, Paul Bebbington, Mai Stafford, Matthias C. Angermeyer, Traolach Brugha: Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. The British Journal of Psychiatry, 2007-07-01 (kohorttitutkimus julkaistu v. 2005), nro 1, s. 30–37. The Royal College of Psychiatrists. PubMed:17602122. doi:10.1192/bjp.bp.105.020982. ISSN 0007-1250. Artikkelin verkkoversio. en
Marie-Caroline Cotel & Ewelina M. Lenartowicz & Sridhar Natesan & Michel M. Modo & Jonathan D. Cooper & Steven C. R. Williams: Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. European Neuropsychopharmacology, 1.11.2015, nro 11, s. 2098–2107. doi:10.1016/j.euroneuro.2015.08.004. ISSN 0924-977X. Artikkelin verkkoversio. English
Rantala Markus J., Luoto Severi, Borráz-León Javier I., Krams Indrikis: Schizophrenia: The new etiological synthesis. Neuroscience and Biobehavioral Reviews, 2022, nro 142. Artikkelin verkkoversio. Viitattu 5.4.2023.
Marc De Hert, Christoph U. Correll, Dan Cohen: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, 1.3.2010, nro 1, s. 68–74. doi:10.1016/j.schres.2009.12.029. ISSN 0920-9964. Artikkelin verkkoversio. en
Carol A. Prescott, Jonathan W. Kuhn, Nancy L. Pedersen: Twin Pair Resemblance for Psychiatric Hospitalization in the Swedish Twin Registry: A 32-year Follow-up Study of 29,602 Twin Pairs. Behavior Genetics, 1.7.2007, nro 4, s. 547–558. doi:10.1007/s10519-007-9143-6. ISSN 0001-8244. Artikkelin verkkoversio. en
Alok Jha, science correspondent: Severe abuse in childhood may treble risk of schizophrenia. The Guardian, 18.4.2012. ISSN 0261-3077. Artikkelin verkkoversio. en-GB
thelancet.com
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607. doi:10.1016/S0140-6736(12)60239-6. ISSN 0140-6736. Artikkelin verkkoversio. English
Trafi: Rautatiemääräys (s. 2 (tehtävät), 5 (sairaudet)) trafi.fi. 15.09.2010, voimassa 03.01.2011 alkaen toistaiseksi. Liikenteen turvallisuusvirasto Trafi. Viitattu 5.1.2017.
J. Karagianis, D. Novick, J. Pecenak, J. M. Haro, M. Dossenbach, T. Treuer: Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*. International Journal of Clinical Practice, 1.11.2009, nro 11, s. 1578–1588. doi:10.1111/j.1742-1241.2009.02191.x. ISSN 1742-1241. Artikkelin verkkoversio. en
worldcat.org
J. Karagianis, D. Novick, J. Pecenak, J. M. Haro, M. Dossenbach, T. Treuer: Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*. International Journal of Clinical Practice, 1.11.2009, nro 11, s. 1578–1588. doi:10.1111/j.1742-1241.2009.02191.x. ISSN 1742-1241. Artikkelin verkkoversio. en
K. Hopper, J. Wanderling: Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophrenia Bulletin, 2000, nro 4, s. 835–846. PubMed:11087016. ISSN 0586-7614. Artikkelin verkkoversio.
Jukka Aaltonen, Jaakko Seikkula, Klaus Lehtinen: The Comprehensive Open-Dialogue Approach in Western Lapland: I. The incidence of non-affective psychosis and prodromal states. Psychosis, 1.10.2011, nro 3, s. 179–191. doi:10.1080/17522439.2011.601750. ISSN 1752-2439. Artikkelin verkkoversio.
Silvia Sorce, Stefania Schiavone, Paolo Tucci, Marilena Colaianna, Vincent Jaquet, Vincenzo Cuomo: The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25.8.2010, nro 34, s. 11317–11325. PubMed:20739552. doi:10.1523/JNEUROSCI.1491-10.2010. ISSN 1529-2401. Artikkelin verkkoversio.
Marie-Caroline Cotel & Ewelina M. Lenartowicz & Sridhar Natesan & Michel M. Modo & Jonathan D. Cooper & Steven C. R. Williams: Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. European Neuropsychopharmacology, 1.11.2015, nro 11, s. 2098–2107. doi:10.1016/j.euroneuro.2015.08.004. ISSN 0924-977X. Artikkelin verkkoversio. English
M. Boyle: Is schizophrenia what it was? A re-analysis of Kraepelin's and Bleuler's population. Journal of the History of the Behavioral Sciences, October 1990, nro 4, s. 323–333. PubMed:2254639. ISSN 0022-5061. Artikkelin verkkoversio.
Diagnostics and determinants of schizophrenia : the Northern Finland 1966 birth cohort study. Oulu: Oulun yliopisto, 2011. 769544195. Teoksen verkkoversio.
Alok Jha, science correspondent: Severe abuse in childhood may treble risk of schizophrenia. The Guardian, 18.4.2012. ISSN 0261-3077. Artikkelin verkkoversio. en-GB
Louise Arseneault, Mary Cannon, Helen L. Fisher, Guilherme Polanczyk, Terrie E. Moffitt, Avshalom Caspi: Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. The American Journal of Psychiatry, January 2011, nro 1, s. 65–72. PubMed:20952460. doi:10.1176/appi.ajp.2010.10040567. ISSN 1535-7228. Artikkelin verkkoversio.
Anne Marsman, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak: Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?. Schizophrenia Bulletin, 1.12.2020, nro 6, s. 1353–1362. doi:10.1093/schbul/sbaa086. ISSN 0586-7614. Artikkelin verkkoversio. en
Alexandros Rammos, Lara A. Neira Gonzalez, Daniel R. Weinberger, Kevin J. Mitchell, Kristin K. Nicodemus: The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia. Neuropsychopharmacology, 2019-08, nro 9, s. 1562–1569. doi:10.1038/s41386-019-0410-z. ISSN 1740-634X. Artikkelin verkkoversio. en
M. Koskenvuo, H. Langinvainio, J. Kaprio, J. Lönnqvist, P. Tienari: Psychiatric Hospitalization in Twins. Acta geneticae medicae et gemellologiae: twin research, 1984/04, nro 2, s. 321–332. doi:10.1017/S0001566000007364. ISSN 0001-5660. Artikkelin verkkoversio.
William Pollin, Martin G. Allen, Axel Hoffer, James R. Stabenau, Zdenek Hrubec: Psychopathology in 15,909 Pairs of Veteran Twins: Evidence for a Genetic Factor in the Pathogenesis of Schizophrenia and Its Relative Absence in Psychoneurosis. American Journal of Psychiatry, 1.11.1969, nro 5, s. 597–610. doi:10.1176/ajp.126.5.597. ISSN 0002-953X. Artikkelin verkkoversio.
P. McGuffin, A. E. Farmer, I. I. Gottesman, R. M. Murray, A. M. Reveley: Twin concordance for operationally defined schizophrenia. Confirmation of familiality and heritability. Archives of General Psychiatry, June 1984, nro 6, s. 541–545. PubMed:6539584. ISSN 0003-990X. Artikkelin verkkoversio.
Carol A. Prescott, Jonathan W. Kuhn, Nancy L. Pedersen: Twin Pair Resemblance for Psychiatric Hospitalization in the Swedish Twin Registry: A 32-year Follow-up Study of 29,602 Twin Pairs. Behavior Genetics, 1.7.2007, nro 4, s. 547–558. doi:10.1007/s10519-007-9143-6. ISSN 0001-8244. Artikkelin verkkoversio. en
Svenn Torgersen: [Genetics and somatoform disorders]. Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, Ny Raekke, 30.5.2002, nro 14, s. 1385–1388. PubMed:12098908. ISSN 0029-2001. Artikkelin verkkoversio.
J. C. Loehlin: Identical twins reared apart and other routes to the same destination. Progress in Clinical and Biological Research, 1978, nro 24A, s. 69–77. PubMed:568284. ISSN 0361-7742. Artikkelin verkkoversio.
Norbert Müller, Markus J. Schwarz: Immune System and Schizophrenia. Current immunology reviews, 2010-8, nro 3, s. 213–220. PubMed:21057585. ISSN 1573-3955. Artikkelin verkkoversio.
Jari Tiihonen, Jari Haukka, Mark Taylor, Peter M. Haddad, Maxine X. Patel, Pasi Korhonen: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. The American Journal of Psychiatry, June 2011, nro 6, s. 603–609. PubMed:21362741. doi:10.1176/appi.ajp.2011.10081224. ISSN 1535-7228. Artikkelin verkkoversio.
Peter Lepping, Rajvinder Singh Sambhi, Richard Whittington, Steven Lane, Rob Poole: Clinical relevance of findings in trials of antipsychotics: systematic review. The British Journal of Psychiatry: The Journal of Mental Science, 2011-05, nro 5, s. 341–345. PubMed:21525517. doi:10.1192/bjp.bp.109.075366. ISSN 1472-1465. Artikkelin verkkoversio.
Stefan Leucht, Claudia Leucht, Maximilian Huhn, Anna Chaimani, Dimitris Mavridis, Bartosz Helfer: Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry, 25.5.2017, nro 10, s. 927–942. doi:10.1176/appi.ajp.2017.16121358. ISSN 0002-953X. Artikkelin verkkoversio.
Ni A. Khin, Yeh-Fong Chen, Yang Yang, Peiling Yang, Thomas P. Laughren: Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. The Journal of Clinical Psychiatry, 2012-06, nro 6, s. 856–864. PubMed:22687813. doi:10.4088/JCP.11r07539. ISSN 1555-2101. Artikkelin verkkoversio.
Alexander M. Récalt, David Cohen: Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017. Psychotherapy and Psychosomatics, 2019, nro 2, s. 105–113. PubMed:30893683. doi:10.1159/000496734. ISSN 1423-0348. Artikkelin verkkoversio.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, Georgia Salanti: Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet, 2.6.2012, nro 9831, s. 2063–2071. PubMed:22560607. doi:10.1016/S0140-6736(12)60239-6. ISSN 0140-6736. Artikkelin verkkoversio. English
P.B. Danborg, P.C. Gøtzsche: Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. The International Journal of Risk & Safety in Medicine, {{{Vuosi}}}, nro 4, s. 193–201. PubMed:31561392. doi:10.3233/JRS-195063. ISSN 0924-6479. Artikkelin verkkoversio.
J. Moilanen, M. Haapea, J. Miettunen, E. Jääskeläinen, J. Veijola, M. Isohanni: Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. European Psychiatry: The Journal of the Association of European Psychiatrists, 2013-01, nro 1, s. 53–58. PubMed:21920710. doi:10.1016/j.eurpsy.2011.06.009. ISSN 1778-3585. Artikkelin verkkoversio.
Roman Kotov, Laura Fochtmann, Kaiqiao Li, Marsha Tanenberg-Karant, Eduardo A. Constantino, Joan Rubinstein: Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. The American Journal of Psychiatry, 11 01, 2017, nro 11, s. 1064–1074. PubMed:28774193. doi:10.1176/appi.ajp.2017.16101191. ISSN 1535-7228. Artikkelin verkkoversio.
Royal College of Psychiatrists and British Psychological Society BMJ Publishing Group Ltd: Review: at least one third of people report persistent memory loss after electroconvulsive therapy. Evidence-Based Mental Health, 1.2.2004, 7. vsk, nro 1, s. 27–27. PubMed:14769671. doi:10.1136/ebmh.7.1.27. ISSN 1362-0347. Artikkelin verkkoversio. en
A. Jablensky, N. Sartorius, G. Ernberg, M. Anker, A. Korten, J. E. Cooper: Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine. Monograph Supplement, 1992, nro 20, s. 1–97. PubMed:1565705. ISSN 0264-1801. Artikkelin verkkoversio.
Jari Tiihonen, Jouko Lönnqvist, Kristian Wahlbeck, Timo Klaukka, Leo Niskanen, Antti Tanskanen: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (London, England), 22.8.2009, nro 9690, s. 620–627. PubMed:19595447. doi:10.1016/S0140-6736(09)60742-X. ISSN 1474-547X. Artikkelin verkkoversio.
Marc De Hert, Christoph U. Correll, Dan Cohen: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, March 2010, nro 1, s. 68–74. PubMed:20060684. doi:10.1016/j.schres.2009.12.029. ISSN 1573-2509. Artikkelin verkkoversio.
Marc De Hert, Christoph U. Correll, Dan Cohen: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, 1.3.2010, nro 1, s. 68–74. doi:10.1016/j.schres.2009.12.029. ISSN 0920-9964. Artikkelin verkkoversio. en
Steven Marwaha, Sonia Johnson, Paul Bebbington, Mai Stafford, Matthias C. Angermeyer, Traolach Brugha: Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. The British Journal of Psychiatry, 2007-07-01 (kohorttitutkimus julkaistu v. 2005), nro 1, s. 30–37. The Royal College of Psychiatrists. PubMed:17602122. doi:10.1192/bjp.bp.105.020982. ISSN 0007-1250. Artikkelin verkkoversio. en
Natasha A. Schvey, Rebecca M. Puhl, Kelly D. Brownell: The Stress of Stigma: Exploring the Effect of Weight Stigma on Cortisol Reactivity. Psychosomatic Medicine, February/March 2014, nro 2, s. 156. doi:10.1097/PSY.0000000000000031. ISSN 0033-3174. Artikkelin verkkoversio.
